C. Purpose of this Guidance, Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol Version 6, 08 Jul 2020, MHRA
- To outline the practical arrangements for notification.
- To provide advice on what should and what should not be classified as a “serious breach” and what must be reported.
- To outline possible actions that may be taken by the MHRA in response to notifications of serious breaches.
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
on demandACROSS Global Training AcademyOnline
-
29 September 2023 – 02 October 2024SCDM (Society of Clinical Data Management)United States
-
21 – 23 May 2024InformaBelgium
-
03 – 04 June 2024The Society for Clinical Research Sites (SCRS)United States
-
16 – 17 July 2024The Society for Clinical Research Sites (SCRS)Australia
-
27 September – 29 October 2024The Society for Clinical Research Sites (SCRS)United States
Prochains essais cliniques
-
National Institute of Medical Sciences and Nutrition...Pas encore de recrutementRhA - Polyarthrite rhumatoïde
-
Institute of Liver and Biliary Sciences, IndiaPas encore de recrutementDéterminer les prédicteurs de réversibilité de l'insuffisance hépatique aiguë ou chronique à 6 mois.Insuffisance hépatique aiguë sur chroniqueInde
-
Centre Leon BerardPas encore de recrutementCancer de l'estomac | Cancer de la jonction œsogastriqueFrance
-
TC Erciyes UniversityRecrutementMaladie endodontiqueTurquie
-
Casa di Cura Privata 'Malzoni - Villa dei Platani...RecrutementOpération | Endométriose profondeItalie
-
Assembly BiosciencesPas encore de recrutementHerpès génital simplex récurrent de type 2Nouvelle-Zélande
-
Cerenovus, Part of DePuy Synthes Products, Inc.Pas encore de recrutementAVC ischémique aiguÉtats-Unis
-
Pamukkale UniversityPas encore de recrutementVessie urinaire, hyperactiveTurquie
-
China-Japan Friendship HospitalPas encore de recrutementObésité | Diabète | Calculs biliaires | Stase biliaire
-
AstraZenecaDaiichi SankyoPas encore de recrutementCancer du sein métastatique | Cancer du sein HER2 positif | Cancer du sein non résécable | Cancer du sein à faible expression HER2Canada
-
Chinese University of Hong KongRecrutement
-
Central Hospital, Nancy, FrancePas encore de recrutement